Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raag
M Whitlow

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|November 15, 1992
Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv moleculesM E Schott, D E Milenic, T Yokota, et al.
The Journal of Biological Chemistry|July 20, 1999
Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthaseH Li, C S Raman, C B Glaser, et al.
The Journal of Biological Chemistry|December 31, 1997
X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complexM Whitlow, A J Howard, D Stewart, et al.
Biochemistry|November 1, 1988
The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test caseM W Pantoliano, M Whitlow, J F Wood, et al.
Cutis|July 1, 1994
New York University therapeutic roundtable: a panel of experts answer questions on the treatment of challenging casesJ L Shupack, N Kanof, L P Stolman, et al.
Cancer Research|December 1, 1991
Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49D E Milenic, T Yokota, D R Filpula, et al.
Journal of Medicinal Chemistry|October 3, 1999
Conformations of trypsin-bound amidine inhibitors of blood coagulant factor Xa by double REDOR NMR and MD simulationsL M McDowell, M A McCarrick, D R Studelska, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Construction and characterization of a single-chain catalytic antibodyR A Gibbs, B A Posner, D R Filpula, et al.
Journal of Medicinal Chemistry|August 25, 2001
X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitorM Whitlow, A J Howard, D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitorsZ Zhao, D O Arnaiz, B Griedel, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|November 15, 1992
Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv moleculesM E Schott, D E Milenic, T Yokota, et al.
The Journal of Biological Chemistry|July 20, 1999
Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthaseH Li, C S Raman, C B Glaser, et al.
The Journal of Biological Chemistry|December 31, 1997
X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complexM Whitlow, A J Howard, D Stewart, et al.
Biochemistry|November 1, 1988
The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test caseM W Pantoliano, M Whitlow, J F Wood, et al.
Cutis|July 1, 1994
New York University therapeutic roundtable: a panel of experts answer questions on the treatment of challenging casesJ L Shupack, N Kanof, L P Stolman, et al.
Cancer Research|December 1, 1991
Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49D E Milenic, T Yokota, D R Filpula, et al.
Journal of Medicinal Chemistry|October 3, 1999
Conformations of trypsin-bound amidine inhibitors of blood coagulant factor Xa by double REDOR NMR and MD simulationsL M McDowell, M A McCarrick, D R Studelska, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Construction and characterization of a single-chain catalytic antibodyR A Gibbs, B A Posner, D R Filpula, et al.
Journal of Medicinal Chemistry|August 25, 2001
X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitorM Whitlow, A J Howard, D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitorsZ Zhao, D O Arnaiz, B Griedel, et al.
Pageof 7